Nickson Philip

Nickson Philip is listed in filings as Chief Business & Legal Officer at Monte Rosa Therapeutics, Inc.. This profile follows SEC Form 4 activity through Apr 10, 2026, including sale activity. Recent filings connect the profile to Monte Rosa Therapeutics, Inc. (GLUE). The current snapshot covers public activity from Jan 6, 2025 to Apr 10, 2026. Reported amounts are shown as $103.4K to $1.9M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.